Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10374	Companies
216189	Keywords
145888	Articles
114464	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 06/09/2025 at 15:05, 11 months 1 day ago

Jaguar Health discute du protocole Crofelemer avec la FDA

Crofelemer Désignation De Médicament Orphelin Approbation De La FDA Cancer Du Sein Métastatique Programme D'accès Élargi
BRIEF

published on 06/09/2025 at 15:05, 11 months 1 day ago

Jaguar Health Discusses Crofelemer Pathway with FDA

Crofelemer FDA Approval Orphan Drug Designation Metastatic Breast Cancer Expanded Access Program
PRESS RELEASE

published on 06/09/2025 at 15:00, 11 months 1 day ago

Jaguar Health Provides Update on Meeting with FDA Discussing Statistically Significant Results of Responder Analysis of Breast Cancer Patients in Phase 3 OnTarget Trial and Potential Approval Pathway for Crofelemer
Jaguar Health's Napo Pharmaceuticals shares plans to seek approval for crofelemer in cancer therapy-related diarrhea for metastatic breast cancer patients. Key discussions with FDA highlighted in Type C Meeting

Napo Pharmaceuticals Crofelemer Jaguar Health Cancer Therapy Metastatic Breast Cancer
BRIEF

published on 06/06/2025 at 15:05, 11 months 4 days ago

Jaguar Health discutera de ses efforts en matière de maladies orphelines lors d'une prochaine discussion informelle.

Napo Pharmaceuticals Crofelemer Jaguar Health Discussion Au Coin Du Feu Maladie Orpheline
BRIEF

published on 06/06/2025 at 15:05, 11 months 4 days ago

Jaguar Health to Discuss Orphan Disease Efforts in Upcoming Fireside Chat

Napo Pharmaceuticals Crofelemer Jaguar Health Fireside Chat Orphan Disease
PRESS RELEASE

published on 06/06/2025 at 15:00, 11 months 4 days ago

Jaguar Health to Conduct Fireside Chat June 10 Regarding Company's Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners’ Spring 2025 Spotlight Series
Jaguar Health's CEO Lisa Conte will participate in a virtual fireside chat on June 10, 2025 to discuss the company's orphan disease development programs

Pharmaceuticals Jaguar Health Lisa Conte Virtual Fireside Chat Orphan Disease Development
BRIEF

published on 05/21/2025 at 14:05, 11 months 20 days ago

Jaguar Health réalise une offre publique d'achat directe enregistrée de 1,5 million de dollars

Nasdaq Placement Privé Jaguar Health Actions Ordinaires Offre Directe
BRIEF

published on 05/21/2025 at 14:05, 11 months 20 days ago

Jaguar Health Conducts $1.5M Registered Direct Offering

Private Placement Nasdaq Jaguar Health Common Stock Direct Offering
PRESS RELEASE

published on 05/21/2025 at 14:00, 11 months 20 days ago

Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Jaguar Health, Inc. announces purchase of 246,306 shares of common stock at $6.09 per share in a registered direct offering. H.C. Wainwright & Co. serves as exclusive placement agent

Shares Stock Purchase Jaguar Health H.C. Wainwright & Co. Direct Offering
BRIEF

published on 05/20/2025 at 15:20, 11 months 21 days ago

Jaguar Health lance un essai de phase 2 pour le Crofelemer chez les patients pédiatriques atteints de MVID

Crofelemer Jaguar Health Essai De Phase 2 MVID Traitement Pédiatrique

Accesswire

Published on 05/09/2026 at 01:55, 1 day 21 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 1 day 22 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 1 day 22 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 23 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 2 days ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/10/2026 at 16:05, 7 hours 47 minutes ago

RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 9 hours 52 minutes ago

MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 12 hours 7 minutes ago

Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 4 hours ago

LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 2 days 3 hours ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations

Les Echos

Published on 05/07/2026 at 19:15, 3 days 4 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 4 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 4 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 4 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 4 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE